pericarditis - Nursing Case Study

Pathophysiology

• Primary mechanism: Inflammation of the pericardium, often due to infections, autoimmune conditions, or myocardial injury, leads to increased vascular permeability and influx of inflammatory cells, resulting in pericardial effusion and chest pain.

• Secondary mechanism: The inflammatory process causes fibrin deposition and potential fibrous thickening, which can restrict cardiac filling, leading to reduced cardiac output and signs of heart failure if chronic or severe.

• Key complication: Tamponade risk, where fluid accumulation exerts pressure on the heart, impeding normal cardiac function and requiring urgent intervention to prevent circulatory collapse.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Hypertension, hyperlipidemia, previous episode of acute pericarditis one year ago

• Current medications: Lisinopril, atorvastatin, ibuprofen

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sharp chest pain, worsens with deep breathing and lying flat

• Key symptoms: Fever, difficulty breathing, fatigue, palpitations

• Vital signs: Temperature 38.3°C (100.9°F), Heart rate 110 bpm, Blood pressure 140/90 mmHg, Respiratory rate 22 breaths per minute, Oxygen saturation 94% on room air

Section 1

As the healthcare team continues to assess the 45-year-old male patient, they note that his symptoms have progressively worsened. Upon further examination, the nurse observes that the patient is exhibiting signs of increased respiratory distress, with his respiratory rate rising to 28 breaths per minute and oxygen saturation dropping to 90% on room air. Additionally, auscultation reveals diminished heart sounds, which could indicate an increase in pericardial effusion. These findings raise concern for cardiac tamponade, a potentially life-threatening complication of pericarditis.

In light of these developments, the physician orders an urgent echocardiogram to assess the extent of pericardial effusion. The echocardiogram reveals a large pericardial effusion with evidence of diastolic collapse of the right atrium, confirming early signs of cardiac tamponade. Concurrently, laboratory tests show elevated inflammatory markers, including a high C-reactive protein (CRP) level of 110 mg/L, suggesting significant ongoing inflammation. Despite the patient's current medication regimen, the decision is made to initiate corticosteroids to address the inflammation more aggressively and to prepare for a potential pericardiocentesis, a procedure to drain excess fluid from the pericardial space.

As the team discusses the next steps, the patient reports increasing fatigue and a sensation of lightheadedness, further emphasizing the urgency of intervention. With the patient's condition teetering on the brink of more severe complications, the healthcare team recognizes the need for prompt action to prevent further deterioration. The patient is prepared for pericardiocentesis, while continuous monitoring of vital signs and cardiac function is maintained to ensure stability. This critical point in the patient's care underscores the importance of timely diagnosis and intervention in mitigating the risk of tamponade and preserving cardiac function.

Section 2

As the healthcare team moves forward with the pericardiocentesis, they are cautiously optimistic about alleviating the patient's symptoms and preventing further complications. However, shortly after the procedure, the patient experiences a sudden drop in blood pressure with a reading of 85/55 mmHg, indicating potential hemodynamic instability. His heart rate increases to 120 beats per minute, and his respiratory rate remains elevated at 30 breaths per minute. Although his oxygen saturation improves to 94% on supplemental oxygen, the team is concerned about the possibility of a vasovagal response or a less common complication like a pneumothorax, given the invasive nature of the procedure.

To further investigate the potential causes of this change in status, a chest X-ray is promptly ordered and reviewed. The imaging confirms a small pneumothorax on the right side, likely a result of the pericardiocentesis. The team quickly implements a conservative management plan, including supplemental oxygen and close monitoring, with the hope that the pneumothorax will resolve without the need for chest tube insertion. Additionally, intravenous fluids are administered to address the patient's hypotension, and a repeat echocardiogram is scheduled to ensure no residual effusion is contributing to his symptoms.

The patient’s response to these interventions is closely monitored, with particular attention to his vital signs and clinical symptoms. Over the next few hours, his blood pressure gradually stabilizes to 100/65 mmHg, and his heart rate decreases to a more controlled 95 beats per minute. Although the patient remains fatigued, his sensation of lightheadedness diminishes, suggesting a positive response to the interventions. The team remains vigilant, aware that the resolution of the pneumothorax and continued management of the inflammatory process are critical to the patient's recovery. They plan to reassess the need for corticosteroids based on his inflammatory markers and overall clinical improvement, ensuring a comprehensive approach to his ongoing care. This stage in the patient's journey highlights the importance of swift, coordinated action and the need for continuous clinical evaluation to adapt to evolving patient needs.

Section 3

As the healthcare team continues to monitor the patient closely, a new set of diagnostic results provides further insights into his condition. The repeat echocardiogram shows no significant residual pericardial effusion, indicating that the pericardiocentesis was largely successful in alleviating the initial fluid buildup. However, laboratory tests reveal an elevated C-reactive protein (CRP) level and a slight increase in white blood cell count, suggesting ongoing inflammation. The team considers these results in the context of the patient's recent procedure and current symptoms, hypothesizing that the inflammatory process associated with pericarditis may be contributing to his persistent fatigue and mild discomfort.

Simultaneously, the patient's respiratory status is reassessed. Although the small pneumothorax initially identified on the chest X-ray appears to be stable, a follow-up X-ray confirms that it has not increased in size, allowing the team to continue with conservative management. The patient's respiratory rate remains elevated at 28 breaths per minute, but he maintains an oxygen saturation of 95% with supplemental oxygen. These findings prompt the team to remain cautious, recognizing the risk of potential complications if the pneumothorax were to enlarge or if the inflammatory response were to exacerbate.

With these diagnostic results in mind, the team deliberates on the appropriate course of action. They decide to initiate a low-dose corticosteroid regimen to address the ongoing inflammation, while continuing to monitor the patient's vital signs and clinical status closely. The plan includes regular assessments of his inflammatory markers and respiratory function to ensure that any changes are promptly addressed. This approach reflects the team's commitment to a balanced strategy, aiming to mitigate inflammation without over-reliance on medications, while remaining vigilant for any signs of new or worsening complications. As the patient progresses through his recovery, the healthcare team remains prepared to adapt their management plan in response to his evolving needs.

Section 4

As the healthcare team continues to manage the patient, they observe a change in his status. Over the next 48 hours, there is a noticeable increase in the patient's fatigue and discomfort, prompting a repeat evaluation. A new set of vital signs reveals a slight increase in his heart rate to 110 beats per minute, while his blood pressure remains stable at 118/76 mmHg. Additionally, the patient's respiratory rate has increased slightly to 30 breaths per minute, though he still maintains an oxygen saturation of 94% on supplemental oxygen. These subtle changes raise concerns among the team about the adequacy of their current management strategy.

A more detailed physical examination reveals that the patient is experiencing mild jugular venous distention and has developed a new pericardial friction rub upon auscultation, which was not previously noted. These findings, combined with the patient's elevated heart rate and increased respiratory effort, suggest that the inflammatory process may be intensifying, potentially leading to a recurrence of pericardial effusion or even the early stages of cardiac tamponade. Recognizing these signs, the team decides to perform an urgent repeat echocardiogram to assess for any new fluid accumulation around the heart.

The results of the echocardiogram confirm the team's suspicions: there is a small but significant recurrence of pericardial effusion. This development underscores the complexity of the patient's condition and the need for a revised intervention strategy. The healthcare team promptly adjusts the corticosteroid dose, increasing it to manage the heightened inflammatory response more aggressively while continuing to monitor the patient closely. They also initiate a plan for potential repeat pericardiocentesis if the patient's condition does not improve or if further complications arise, emphasizing their commitment to proactive and responsive care.

Section 5

As the healthcare team implements the revised intervention strategy, they continue to closely monitor the patient for any signs of improvement or deterioration. Over the next 24 hours, the patient's vitals provide mixed signals. His heart rate remains elevated at 112 beats per minute, and his respiratory rate stabilizes slightly at 28 breaths per minute. However, he begins to exhibit new symptoms of intermittent chest pain and shortness of breath, particularly when lying flat, prompting the team to consider the possibility of evolving cardiac tamponade.

Laboratory tests, including a complete blood count and inflammatory markers, reveal an increase in the patient's white blood cell count to 14,500/µL and elevated C-reactive protein levels, indicating a persistent inflammatory response. Despite the increased corticosteroid dosage, these markers of inflammation suggest that the patient's condition may not be responding adequately to the current treatment regimen. Furthermore, his oxygen saturation has slightly decreased to 92% on the same level of supplemental oxygen, suggesting impaired gas exchange potentially due to compromised cardiac function.

Recognizing the potential for further complications, the healthcare team decides to proceed with a cautious pericardiocentesis to relieve the pressure on the heart and improve hemodynamics. This decision is based on the combination of clinical findings, including persistent jugular venous distention, muffled heart sounds, and hypotension, which collectively raise the suspicion of cardiac tamponade. The team prepares for the procedure while ensuring that they have the necessary resources and personnel to respond to any emergent situations, demonstrating their commitment to proactive patient care and clinical reasoning. This step in the patient's journey highlights the delicate balance between aggressive intervention and careful monitoring in the management of complex pericarditis cases.